In this issue of Current Oncology

125 CURRENT ONCOLOGY—VOLUME 14, NUMBER 4 We are delighted to inform the readership of Current Oncology that Dr. Richard J. Ablin, from the University of Arizona College of Medicine and the Arizona Cancer Center, has agreed to join Dr. Phil Gold as co-deputy editor. We welcome Richard, who has served on the editorial board of Current Oncology since 1998 and who is currently co-editor with Phil Gold of our section on Updates and Developments in Oncology. In their respective roles, Phil and Richard will work together, with the help of our section editors, to expand the base of submissions from across Canada and the United States. In this regard, we look to you, our readership, for input about the kind of material that you would like to see—and indeed for original articles for publication in your specific areas of interest and expertise, and for reviews of areas that have experienced rapid progress on the clinical side. Furthermore, Phil and Richard, together with other members of our staff, will be interfacing with industry and other stakeholders in the oncology community throughout North America while promoting Current Oncology and working to further enhance the impact value of the journal. We anticipate that these exciting changes will bring Current Oncology to the next level, thereby filling a niche for not only for specialists in clinical oncology, but also for family physicians who have taken on major responsibilities in meeting the needs of cancer patients. In the process, we trust that Current Oncology will become an invaluable resource for the Canadian oncology community. ~